Cattaneo R - Search Results

1

Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic mice.

Peng KW, Frenzke M, Myers R, Soeffker D, Harvey M, Greiner S, Galanis E, Cattaneo R, Federspiel MJ, Russell SJ. Peng KW, et al. Among authors: cattaneo r. Hum Gene Ther. 2003 Nov 1;14(16):1565-77. doi: 10.1089/104303403322495070. Hum Gene Ther. 2003. PMID: 14577918

2

Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.

Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, Cattaneo R, Russell SJ, Vile RG. Bateman A, et al. Among authors: cattaneo r. Cancer Res. 2000 Mar 15;60(6):1492-7. Cancer Res. 2000. PMID: 10749110

3

Recombinant measles viruses efficiently entering cells through targeted receptors.

Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R. Schneider U, et al. Among authors: cattaneo r. J Virol. 2000 Nov;74(21):9928-36. doi: 10.1128/jvi.74.21.9928-9936.2000. J Virol. 2000. PMID: 11024120 Free PMC article.

4

Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen.

Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R. Hammond AL, et al. Among authors: cattaneo r. J Virol. 2001 Mar;75(5):2087-96. doi: 10.1128/JVI.75.5.2087-2096.2001. J Virol. 2001. PMID: 11160713 Free PMC article.

5

Roles of macrophages in measles virus infection of genetically modified mice.

Roscic-Mrkic B, Schwendener RA, Odermatt B, Zuniga A, Pavlovic J, Billeter MA, Cattaneo R. Roscic-Mrkic B, et al. Among authors: cattaneo r. J Virol. 2001 Apr;75(7):3343-51. doi: 10.1128/JVI.75.7.3343-3351.2001. J Virol. 2001. PMID: 11238860 Free PMC article.

6

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice.

Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA, Fielding AK. Grote D, et al. Among authors: cattaneo r. Blood. 2001 Jun 15;97(12):3746-54. doi: 10.1182/blood.v97.12.3746. Blood. 2001. PMID: 11389012 Free article.

7

Systemic therapy of myeloma xenografts by an attenuated measles virus.

Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ. Peng KW, et al. Among authors: cattaneo r. Blood. 2001 Oct 1;98(7):2002-7. doi: 10.1182/blood.v98.7.2002. Blood. 2001. PMID: 11567982 Free article.

8

Efficiency of measles virus entry and dissemination through different receptors.

Schneider U, von Messling V, Devaux P, Cattaneo R. Schneider U, et al. Among authors: cattaneo r. J Virol. 2002 Aug;76(15):7460-7. doi: 10.1128/jvi.76.15.7460-7467.2002. J Virol. 2002. PMID: 12097558 Free PMC article.

9

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ. Peng KW, et al. Among authors: cattaneo r. Blood. 2003 Apr 1;101(7):2557-62. doi: 10.1182/blood-2002-07-2195. Epub 2002 Nov 14. Blood. 2003. PMID: 12433686 Free article.

10

An oncolytic measles virus engineered to enter cells through the CD20 antigen.

Bucheit AD, Kumar S, Grote DM, Lin Y, von Messling V, Cattaneo RB, Fielding AK. Bucheit AD, et al. Mol Ther. 2003 Jan;7(1):62-72. doi: 10.1016/s1525-0016(02)00033-3. Mol Ther. 2003. PMID: 12573619 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters